Loading clinical trials...
Loading clinical trials...
This real-world study will assess the efficacy and safety of luspatercept treatment for β-thalassemia major in Taiwan as well as the impact on quality of life.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT06468423 · Pateints of β-thalassemia Major With Iron Overload
NCT04205435 · β-thalassemia Major
NCT00390858 · Transfusional Iron Overload, β-thalassemia Major, and more
NCT01846923 · Asplenia, β-thalassemia Major
Local Institution - 02
Kaohsiung City
Local Institution - 04
Tainan
Local Institution - 01
Taipei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions